Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 2.83x is 44% below its estimated 1-year average of 5.09x, near the low end of its estimated 1-year range (2.69x–7.61x).
As of 2026-10-06T18:52:58.738Z.
Calculation as of: 2026-10-06T18:52:58.738Z.
Quote observation: 2026-10-06T18:49:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87d00981f6afc2d6fb42b8babadf75d30967326f42a5e12d4c63051d6ceded83
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
2.83x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.33x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
-34.64%
vs the sector median at left
Atrium Therapeutics, Inc.
Market Cap
$137.38M
EV/Sales Ratio
2.83x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$138.16M
EV/Sales Ratio
2.95x
TTM Avg
4.86x
3Y Avg
4.26x
5Y Avg
4.45x
Market Cap
$138.85M
EV/Sales Ratio
6.39x
TTM Avg
9.42x
3Y Avg
15.43x
5Y Avg
15.43x
Market Cap
$136.44M
EV/Sales Ratio
0.65x
TTM Avg
0.92x
3Y Avg
0.93x
5Y Avg
2.04x
Market Cap
$140.54M
EV/Sales Ratio
N/A
TTM Avg
87090.85x
3Y Avg
33916.84x
5Y Avg
33916.84x
Market Cap
$142.06M
EV/Sales Ratio
2.16x
TTM Avg
2.70x
3Y Avg
2.25x
5Y Avg
3.83x
Market Cap
$133.01M
EV/Sales Ratio
0.83x
TTM Avg
0.85x
3Y Avg
1.35x
5Y Avg
2.44x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $137.38M | 2.83x | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.16M | 2.95x | 4.86x | 4.26x | 4.45x |
| Alpha Cognition Inc (ACOG)vs › | $138.85M | 6.39x | 9.42x | 15.43x | 15.43x |
| Organigram Global Inc. (OGI)vs › | $136.44M | 0.65x | 0.92x | 0.93x | 2.04x |
| Freenome, Inc. (FRNM)vs › | $135.74M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $140.54M | N/A | 87090.85x | 33916.84x | 33916.84x |
| LifeMD, Inc. (LFMD)vs › | $133.24M | 0.56x | 0.71x | 1.29x | 1.09x |
| Sutro Biopharma, Inc. (STRO)vs › | $142.06M | 2.16x | 2.70x | 2.25x | 3.83x |
| Health Catalyst, Inc. (HCAT)vs › | $133.01M | 0.83x | 0.85x | 1.35x | 2.44x |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.98M | 1.22x | 2.03x | 2.11x | 2.84x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 2.78x |
| 2026-10-02 | 2.69x |
| 2026-10-01 | 2.91x |
| 2026-09-30 | 3.01x |
| 2026-09-29 | 3.11x |
| 2026-09-28 | 3.11x |
| 2026-09-25 | 3.02x |
| 2026-09-24 | 2.94x |
| 2026-09-23 | 3.04x |
| 2026-09-22 | 3.69x |
| 2026-09-21 | 3.67x |
| 2026-09-18 | 3.50x |
| 2026-09-17 | 3.94x |
| 2026-09-16 | 3.90x |
| 2026-09-15 | 4.33x |
| 2026-09-14 | 4.41x |
| 2026-09-11 | 4.52x |
| 2026-09-10 | 4.51x |
| 2026-09-09 | 4.63x |
| 2026-09-08 | 5.24x |
| 2026-09-04 | 7.31x |
| 2026-09-03 | 7.61x |
| 2026-09-02 | 7.22x |
| 2026-09-01 | 7.00x |
| 2026-08-31 | 6.68x |
| 2026-08-28 | 6.91x |
| 2026-08-27 | 7.16x |
| 2026-08-26 | 7.06x |
| 2026-08-25 | 7.17x |
| 2026-08-24 | 6.90x |
| 2026-08-21 | 6.59x |
| 2026-08-20 | 6.79x |
| 2026-08-19 | 6.96x |
| 2026-08-18 | 6.33x |
| 2026-08-17 | 6.41x |
| 2026-08-14 | 6.33x |
